ATE147787T1 - Verfahren zur herstellung von polypeptiden in einem zellfreien system - Google Patents

Verfahren zur herstellung von polypeptiden in einem zellfreien system

Info

Publication number
ATE147787T1
ATE147787T1 AT90912892T AT90912892T ATE147787T1 AT E147787 T1 ATE147787 T1 AT E147787T1 AT 90912892 T AT90912892 T AT 90912892T AT 90912892 T AT90912892 T AT 90912892T AT E147787 T1 ATE147787 T1 AT E147787T1
Authority
AT
Austria
Prior art keywords
substrates
cell
products
free system
utp
Prior art date
Application number
AT90912892T
Other languages
English (en)
Inventor
Vladimir Ivanovich Baranov
Ljubov Anatolievna Ryabova
Oleg Bronislavovich Yarchuk
Alexandr Sergeevich Spirin
Original Assignee
Inst Of Protein Research Russi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SU4823743 external-priority patent/RU1839191C/ru
Application filed by Inst Of Protein Research Russi filed Critical Inst Of Protein Research Russi
Application granted granted Critical
Publication of ATE147787T1 publication Critical patent/ATE147787T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/585Calcitonins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Details
    • C12N2795/10011Details dsDNA Bacteriophages
    • C12N2795/10211Podoviridae
    • C12N2795/10222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90912892T 1989-07-31 1990-06-14 Verfahren zur herstellung von polypeptiden in einem zellfreien system ATE147787T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SU4717700 1989-07-31
SU4823743 RU1839191C (ru) 1990-05-29 1990-05-29 Способ получени полипептидов в бесклеточной системе трансл ции

Publications (1)

Publication Number Publication Date
ATE147787T1 true ATE147787T1 (de) 1997-02-15

Family

ID=26666213

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90912892T ATE147787T1 (de) 1989-07-31 1990-06-14 Verfahren zur herstellung von polypeptiden in einem zellfreien system

Country Status (7)

Country Link
US (1) US6399323B1 (de)
EP (1) EP0593757B1 (de)
AT (1) ATE147787T1 (de)
CA (1) CA2064754C (de)
DE (1) DE69029744T2 (de)
DK (1) DK0593757T3 (de)
WO (1) WO1991002076A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2904583B2 (ja) * 1991-10-11 1999-06-14 プロメガ・コーポレーション 真核無細胞抽出物中での転写と翻訳の共役
US5665563A (en) * 1991-10-11 1997-09-09 Promega Corporation Coupled transcription and translation in eukaryotic cell-free extract
AU4930993A (en) * 1992-09-24 1994-04-12 Public Health Research Institute Of The City Of New York, Inc., The Coupled replication-translation methods and kits for protein synthesis
WO1996014428A1 (en) * 1994-11-08 1996-05-17 Novagen, Inc. Method for in vitro protein synthesis
US6537776B1 (en) 1999-06-14 2003-03-25 Diversa Corporation Synthetic ligation reassembly in directed evolution
AU3152797A (en) * 1996-06-07 1998-01-05 Genentech Inc. Methods for (in vitro) protein synthesis
US5968767A (en) * 1996-06-07 1999-10-19 Genentech, Inc. Methods for in vitro protein synthesis
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
RU2148649C1 (ru) * 1998-03-31 2000-05-10 Институт белка РАН Способ получения полипептидов в бесклеточной системе (варианты) и устройство для его осуществления
RU2169154C2 (ru) * 1999-03-25 2001-06-20 Институт белка РАН Способ получения полипептидов в бесклеточной системе
DE60042209D1 (de) * 1999-08-20 2009-06-25 Pasteur Institut Enzymatische synthese von deoxyribonucleotiden
DE10011209A1 (de) 2000-03-08 2001-09-13 Roche Diagnostics Gmbh Matrix-Reaktor und Verfahren zur Herstellung von Produkten in diesem Reaktor
JP3750020B2 (ja) * 2000-12-07 2006-03-01 学校法人慶應義塾 C末端修飾タンパク質およびその製造方法、ならびに、c末端修飾タンパク質の製造に用いる修飾剤および翻訳テンプレート、ならびに、c末端修飾タンパク質を用いたタンパク質相互作用の検出方法
GB0115841D0 (en) 2001-06-28 2001-08-22 Medical Res Council Ligand
DE10137792A1 (de) 2001-08-06 2003-02-27 Erdmann Volker Verfahren zur Genexpression
AU2002333526B2 (en) 2001-09-10 2008-01-17 Meso Scale Technologies, Llc. Methods and apparatus for conducting multiple measurements on a sample
DK1440083T3 (da) 2001-10-25 2013-03-25 Medical Res Council Molekyler
US20030162209A1 (en) * 2001-12-19 2003-08-28 George Martin PCR based high throughput polypeptide screening
US20030119091A1 (en) * 2001-12-20 2003-06-26 Toru Ezure Cell-free protein synthesis method and extract solution therefor
WO2003064672A1 (fr) * 2002-01-31 2003-08-07 Yaeta Endo Extrait cellulaire pour synthese de proteine acellulaire et procede de production de cet extrait
WO2003074546A2 (de) 2002-03-01 2003-09-12 Erdmann Volker A Streptavidin-bindungspeptid
US20060002935A1 (en) 2002-06-28 2006-01-05 Domantis Limited Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
US9321832B2 (en) 2002-06-28 2016-04-26 Domantis Limited Ligand
CN101724071A (zh) 2004-10-08 2010-06-09 杜门蒂斯有限公司 抗肿瘤坏死因子受体1的单域抗体及其使用方法
JP2008532559A (ja) 2005-03-19 2008-08-21 メディカル リサーチ カウンシル ウイルス感染の治療及び予防又は治療及び予防の改善
WO2008060448A2 (en) 2006-11-10 2008-05-22 Massachusetts Institute Of Technology Small molecule pak inhibitors
JP2010043063A (ja) 2008-05-09 2010-02-25 Agency For Science Technology & Research 川崎病の診断及び治療
US9309314B2 (en) 2013-12-03 2016-04-12 Agency For Science, Technology And Research (A*Star) Polypeptides, nucleic acids and uses thereof
WO2020159445A1 (en) 2019-01-31 2020-08-06 Agency For Science, Technology And Research Cnx/erp57 inhibitor for use in the treatment or prevention of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1618761A1 (ru) * 1987-04-29 1991-01-07 Институт Белка Ан Ссср Способ получени пептидов и белков в бесклеточной системе трансл ции

Also Published As

Publication number Publication date
CA2064754C (en) 1996-06-18
DE69029744D1 (de) 1997-02-27
CA2064754A1 (en) 1991-02-01
EP0593757A4 (de) 1992-05-08
EP0593757B1 (de) 1997-01-15
DE69029744T2 (de) 1997-07-10
US6399323B1 (en) 2002-06-04
DK0593757T3 (da) 1997-07-07
WO1991002076A1 (en) 1991-02-21
EP0593757A1 (de) 1994-04-27

Similar Documents

Publication Publication Date Title
DE69029744D1 (de) Verfahren zur herstellung von polypeptiden in einem zellfreien system
DE3878821D1 (de) Verfahren zur herstellung von polypeptiden in zellfreien translationssystemen.
SU1705302A1 (ru) Способ препаративной экспрессии генов в бесклеточной системе сопр женной транскрипции/трансл ции
ATE90944T1 (de) Fuer ein hirudinaehnliches protein kodierende dns- sequenz und verfahren zur herstellung eines solchen proteins.
DE3854125D1 (de) VERBESSERTES VERFAHREN ZUR HERSTELLUNG VON FAKTOR VIII:c-TYP-PROTEINEN.
DE69931479D1 (de) Verfahren zur herstellung von polypeptiden in einem zellfreien system und vorrichtung zu deren ausführung
Stadler et al. Isolation of synaptosomal plasma membranes from cholinergic nerve terminals and a comparison of their proteins with those of synaptic vesicles
DE60129717D1 (de) Verfahren zur synthese von zellfreien proteinen
ATE449850T1 (de) Mutanten von flt3-l und ihre verwendungen
DE69029657D1 (de) Menschliches cytokin, interleukin-9
ATE45770T1 (de) Verfahren zur biotechnischen herstellung von rhamnolipiden und rhamnolipide mit nur einem beta-hydroxidecancarbonsaeurerest im molekuel.
DE60030999D1 (de) Verfahren zur herstellung von teilchen
DE58905821D1 (de) Verfahren zur Herstellung von Des-B30-Insulinen und Des-B30-Insulinderivaten.
SE8703539D0 (sv) Artificiell gen och proteinprodukt
MacLeod et al. An internal deletion mutant of a myosin heavy chain in Caenorhabditis elegans.
DK0562508T3 (da) Nyt knogle-relateret protein OSF-2, fremgangsmåde til dets fremstilling samt farmaceutisk præparat med indhold deraf
ES2059854T3 (es) Nuevo polipeptido y su produccion.
Righetti et al. Continuous enzymatic hydrolysis of β‐casein and isoelectric collection of some of the biologically active peptides in an electric field
DE3682721D1 (de) Peptidaminoalkoholderivate, welche ein tetrasubstituiertes kohlenstoffatom besitzen, hemmungsstoffe von renin und proteasesaeuren, verfahren zur herstellung und pharmazeutische zusammensetzungen.
ATE130633T1 (de) Verfahren zur herstellung von polypeptiden in einem zellfreien translationssystem.
ATE263239T1 (de) Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)
DE69613984D1 (de) Für die protein-kinase a-spezifische modifizierte oligonukleotide und verfahren zur deren verwendung
ATE22651T1 (de) Verfahren zum reinigen bzw. anreichern von biologisch aktiven proteinen und hierzu geeignetes mittel.
DE68926922D1 (de) Verfahren zur Herstellung von L-alpha-Aminosäuren
ATE305486T1 (de) Verfahren zur modifizierung von polymeroberflächen